Apoptosis & Cancer Science
Tentative Date: March, 2022
Submit Abstract
Join as an Editor
Apoptosis & Cancer Science
Short Description: Apoptosis is the process of programmed cell death (PCD) that may occur in multicellular organisms. Biochemical events lead to characteristic cell changes (morphology) and death. These changes include blebbing, cell shrinkage, nuclear fragmentation, chromatin condensation, and chromosomal DNA fragmentation.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the execution and analysis, and for the study and detection of apoptosis within and outside the area of cancer research. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Apoptotic pathway , Autophagy, Cancer, Cancer cell subtypes, Cellular biology techniques, Cellular processes, In vitro, In vivo, Molecular techniques, Programmed cell death, Proteasome activation, Tumor
Schedule:
Confirmation deadline: February 25, 2022
Manuscript submission deadline: March 10, 2022
Revision Due:March 20, 2022
Release of special issue: March 20, 2022
Description
Current Evidence-Based Treatment for Gynecologic Cancer
Tentative Date: March, 2022
Submit Abstract
Join as an Editor
Current Evidence-Based Treatment for Gynecologic Cancer
Short Description: Gynecologic Cancers is cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer and vulvar cancer.
Gynecologic Cancers are the Abnormal vaginal bleeding or discharge, Pelvic pain or pressure, Abdominal or back pain, Bloating, Changes in bathroom habits (increased urination, constipation, diarrhea),Itching or burning of the vulva, Changes in vulva color or skin (rash, sores, warts, ulcers).
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the preventive and control measures involved with Gynecologic Oncology. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Vulvar cancer; Chemotherapy; Squamous vulvar cancer; Lymphadenectomy; Reconstruction; Perforator flap; Vulva; Vagina; Endometrial cancer: Ovarian cancer etc.,
Schedule:
Confirmation deadline: February 25, 2022
Manuscript submission deadline: March 10, 2022
Revision Due:March 20, 2022
Release of special issue: March 20, 2022
Description
Tumor Biology and Treatment of Cancer
Lead Editor : Alireza Heidari, California South University (CSU), USA.
Lead Editor : Dr. Deepak Parashar, The University of Warwick, UK.
Tentative Date: March, 2022
Submit Abstract
Join as an Editor
Tumor Biology and Treatment of Cancer
Lead Editor : Alireza Heidari, California South University (CSU), USA.
Lead Editor : Dr. Deepak Parashar, The University of Warwick, UK.
Short Description: The majority of cancer-related mortality is due to metastasis or the spreading of tumors, a facet of cancer that is difficult to target therapeutically.
Aims & Scope:In this special issue the editor asks the responsible authors to review the latest understanding of all aspects of tumor markers and tumor targeting, but studies in other areas of clinical and translational cancer research are also considered. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Clinical Tumor Biology & Immunotherapy, Tumor heterogeneity and metastasis, Tumor microenvironment, Epithelial-mesenchymal transition and angiogenesis, Invasion and migration of cells etc.,
Schedule:
Confirmation deadline: February 25, 2022
Manuscript submission deadline: March 10, 2022
Revision Due:March 20, 2022
Release of special issue: March 20, 2022
Description
Early Diagnosis and Treatment of Lung Cancer
Tentative Date: March, 2022
Submit Abstract
Join as an Editor
Early Diagnosis and Treatment of Lung Cancer
Guest Editor (s) : Erminia Massarelli,The University of Texas MD Anderson Cancer Center,USA.
Guest Editor (s) : Chunxue Bai,Fudan University,China
Short Description: Lung Cancer is s the uncontrolled growth of abnormal cells that start off in one or both lungs; usually in the cells that line the air passages. The abnormal cells do not develop into healthy lung tissue, they divide rapidly and form tumors. As tumors become larger and more numerous, they undermine the lung’s ability to provide the bloodstream with oxygen. Tumors that remain in one place and do not appear to spread are known as “benign tumors”
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the preventive and control measures involved with Lung cancer. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Lung cancer screening; LDCT; Pittsburgh Predictor; Lung cancer risk prediction; Non-small cell lung cancer: Multiple lung cancer; Chemotherapy etc.,
Schedule:
Confirmation deadline: February 25, 2022
Manuscript submission deadline: March 10, 2022
Revision Due:March 20, 2022
Release of special issue: March 20, 2022
Description
Carcinogenesis & Mutagenesis
Tentative Date: March, 2022
Submit Abstract
Join as an Editor
Carcinogenesis & Mutagenesis
Short Description: Carcinogenesis is literally the 'creation' of cancer. It is a process by which normal cells are transformed into cancer cells. Mutagenesis is a process by which the genetic information of an organism is changed in a stable manner, resulting in a mutation. It may occur spontaneously in nature, or as a result of exposure to mutagens.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the evaluation and characterization of carcinogens and mutagens and also the application of current methods in molecular and cellular biology. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Carcinogenesis, Mutagenesis, Change in genetic material of organism, How and why mutations occur, Cancer causes, Role of radiation etc.,
Schedule:
Confirmation deadline: February 25, 2022
Manuscript submission deadline: March 10, 2022
Revision Due:March 20, 2022
Release of special issue: March 20, 2022
Description
Lead Editor : Sergey Malchenko,University of Illinois,USA
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Apoptosis & Cancer Science
Lead Editor : Sergey Malchenko,University of Illinois,USA
Short Description: Apoptosis is the process of programmed cell death (PCD) that may occur in multicellular organisms. Biochemical events lead to characteristic cell changes (morphology) and death. These changes include blebbing, cell shrinkage, nuclear fragmentation, chromatin condensation, and chromosomal DNA fragmentation.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the execution and analysis, and for the study and detection of apoptosis within and outside the area of cancer research. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Apoptotic pathway , Autophagy, Cancer, Cancer cell subtypes, Cellular biology techniques, Cellular processes, In vitro, In vivo, Molecular techniques, Programmed cell death, Proteasome activation, Tumor
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Guest Editor: William Russell Robinson, Tulane University School of Medicine, USA
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Current Evidence-Based Treatment for Gynecologic Cancer
Guest Editor: William Russell Robinson, Tulane University School of Medicine, USA
Short Description: Gynecologic Cancers is cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer and vulvar cancer.
Gynecologic Cancers are the Abnormal vaginal bleeding or discharge, Pelvic pain or pressure, Abdominal or back pain, Bloating, Changes in bathroom habits (increased urination, constipation, diarrhea),Itching or burning of the vulva, Changes in vulva color or skin (rash, sores, warts, ulcers).
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the preventive and control measures involved with Gynecologic Oncology. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Vulvar cancer; Chemotherapy; Squamous vulvar cancer; Lymphadenectomy; Reconstruction; Perforator flap; Vulva; Vagina; Endometrial cancer: Ovarian cancer etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Guest Editor : Clement G. Yedjou,Jackson State University,USA.
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Tumor Biology and Treatment of Cancer
Guest Editor : Clement G. Yedjou,Jackson State University,USA.
Short Description: The majority of cancer-related mortality is due to metastasis or the spreading of tumors, a facet of cancer that is difficult to target therapeutically.
Aims & Scope:In this special issue the editor asks the responsible authors to review the latest understanding of all aspects of tumor markers and tumor targeting, but studies in other areas of clinical and translational cancer research are also considered. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Clinical Tumor Biology & Immunotherapy, Tumor heterogeneity and metastasis, Tumor microenvironment, Epithelial-mesenchymal transition and angiogenesis, Invasion and migration of cells etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Guest Editor : Tatiana Hurtado de Mendoza, University of California,USA.
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Advances in Cancer Immunotherapy
Guest Editor : Tatiana Hurtado de Mendoza, University of California,USA.
Short Description: Cancer immunotherapy is a branch of immunology that studies interactions between the immune system and cancer cells. It is a growing field of research that aims to discover innovative cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, is of particular interest in the field as knowledge gained drives the development of targeted therapy and tumor marker-based diagnostic tests.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding forum for new concepts and advances in basic, translational, and clinical cancer immunology and immunotherapy. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Immunotherapy of cancer; LAK cells: Lipsomes; Active targeting; Passive targeting; Gene theraphy; Stealth technologies; Immunotheraphy; Target cell dragging;Interleukin 2; etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Guest Editor : Yi-Hong Zhou,University of California,USA
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Advances in Brain Cancer Research
Guest Editor : Yi-Hong Zhou,University of California, USA.
Short Description: A brain tumor occurs when abnormal cells form within the brain. There are two main types of tumors: malignant or cancerous tumors and benign tumors. Cancerous tumors can be divided into primary tumors that start within the brain, and secondary tumors that have spread from somewhere else, known as brain metastasis tumors
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of developing new drugs, new imaging techniques, and advanced methods of diagnosing brain tumors and also support research that will improve the quality of life of brain tumor survivors and their caregivers. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Brain cancer: Disease mapping; Cancer therapies: Dose protraction factor; Tumour; Headache; Neuro-oncology; Clinical neurology etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Cancer Metabolism and Biomarkers
Guest Editor: Angela, University of South Florida, USA
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Cancer Metabolism and Biomarkers
Guest Editor: Angela, University of South Florida, USA
Short Description: To share best practice and discuss topics pertinent to all NCDs (Noncommunicable disesases) and also with respect to the full spectrum of cancer control, NCDs are embedded throughout, relating to risk factors, advocacy, patient rights, palliative care.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the prevention, screening, diagnosis, treatment, survivorship and palliative care of Cancer (and/or NCDs). This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Cancer control-planning and monitoring, Complexity, Cancer control, Cancer strategy, Knowledge management, Knowledge transfer etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Chemotherapy & Radiology
Guest Editor : Juong G. Rhee,University of Maryland ,USA
Guest Editor : Praveen Kandi, ScieGen Pharmaceuticals Inc,USA
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Chemotherapy & Radiology
Guest Editor : Juong G. Rhee,University of Maryland, USA
Guest Editor : Praveen Kandi, ScieGen Pharmaceuticals Inc, USA
Short Description: Chemotherapy is a type of cancer treatment that uses drugs to destroy cancer cells. It works by stopping or slowing the growth of cancer cells, which grow and divide quickly. But it can also harm healthy cells that divide quickly, such as those that line your mouth and intestines or cause your hair to grow. Damage to healthy cells may cause side effects. Often, side effects get better or go away after chemotherapy is over.
Radiology is a medical specialty that uses imaging to diagnose and treat disease seen within the body. Radiologists use a variety of imaging techniques such as X-ray radiography, ultrasound, computed tomography (CT), nuclear medicine including positron emission tomography (PET), and magnetic resonance imaging (MRI) to diagnose and/or treat diseases.
Aims & Scope: In this special issue the editor asks the responsible authors to review on all aspects of chemotherapy and radiation therapy and also, covering the pathogenesis, diagnosis, treatment, and control of infection, including treatment with anticancer drugs. Experimental studies , pharmacokinetics and reports on epidemiology and clinical trials are also included. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Drug design, Development approaches for cancer therapeutics, Chemotherapy, Radiotherapy, Telomerase, Telomeres, Anticancer therapeutics, Pathway Database, Egfr Signaling, Warburg effect etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Early Diagnosis and Treatment of Lung Cancer
Guest Editor (s) : Erminia Massarelli,The University of Texas MD Anderson Cancer Center,USA.
Chunxue Bai,Fudan University,China
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Early Diagnosis and Treatment of Lung Cancer
Guest Editor (s) : Erminia Massarelli,The University of Texas MD Anderson Cancer Center,USA.
Guest Editor (s) : Chunxue Bai,Fudan University,China
Short Description: Lung Cancer is s the uncontrolled growth of abnormal cells that start off in one or both lungs; usually in the cells that line the air passages. The abnormal cells do not develop into healthy lung tissue, they divide rapidly and form tumors. As tumors become larger and more numerous, they undermine the lung’s ability to provide the bloodstream with oxygen. Tumors that remain in one place and do not appear to spread are known as “benign tumors”
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the preventive and control measures involved with Lung cancer. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Lung cancer screening; LDCT; Pittsburgh Predictor; Lung cancer risk prediction; Non-small cell lung cancer: Multiple lung cancer; Chemotherapy etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Cancer Vaccines
Guest Editor (s) : Dhastagir S Sheriff, Benghazi University, Libya
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Cancer Vaccines
Editor(s):
Short Description: Vaccines can help to protect us from infection and the diseases it can cause. But they can also be used to treat and prevent some types of cancer. Vaccines deliver tiny amounts of proteins into the body. Depending on the vaccine, these proteins might come from viruses, bacteria or cancer cells but they are not capable of causing disease. Cancer vaccines help the immune system to recognize and attack cancer cells.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of all aspects of vaccines to treat various types of cancer and also various technologies supporting clinical research. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Immunotherapy, Cancer immunotherapy, HPV vaccine, Coley's toxins, Antigen vaccines, Autologous cancer vaccines. etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Pediatric Oncology
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Pediatric Oncology
Editor(s):
Short Description: Pediatric Oncology concerned with the treatment of cancer in children. A cancer diagnosis is upsetting at any age, but especially so when the patient is a child. Most cancers in children, like those in adults, are thought to develop as a result of mutations in genes that lead to uncontrolled cell growth and eventually cancer.
Aims & Scope: In this Special Issue the editor asks the responsible authors to review the basic understanding on the research and treatment of childhood cancers, forefront of developing new treatments and designing clinical trials and also making new discoveries to improve the lives of children with cancer .This Special Issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Oncology; Pediatric; Drug development; Paediatric Investigation Plan; Precompetitive development; Hematology–Oncology; Tumour evaluation etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Clinical Oncology : Diagnosis & Therapy
Lead Editor: Deepak Parashar, University of Warwick, UK.
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Clinical Oncology : Diagnosis & Therapy
Lead Editor: Deepak Parashar, Assistant Professor, University of Warwick, UK.
Short Description: Oncology is a branch of medicine that deals with tumors. Clinical oncology embraces the non-surgical aspect of oncology. It covers both the therapeutic administration of ionizing radiation (radiotherapy) and cytotoxic chemotherapy.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest advancements involved in explaining all types of malignant disease, including pathology, diagnosis and therapy, including radiotherapy, and systemic treatment. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: Dose Distributions, Various therapies involved for curing oncology, Clinical trials, Clinical pharmacy , Biostatistics etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Molecular and Cellular Basis of Breast Cancer
Guest Editor : Angela Poff, Research Associate,University of South Florida,USA
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Molecular and Cellular Basis of Breast Cancer
Guest Editor : Angela Poff, Research Associate,University of South Florida,USA
Short Description: Breast cancer is a malignant tumor that starts in the cells of the breast. A malignant tumor is a group of cancer cells that can grow into (invade) surrounding tissues or spread (metastasize) to distant areas of the body.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding on all areas of breast cancer research and treatment and also studies clinical, epidemiological studies and laboratory investigations regarding breast cancer.. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Breast cancer; Estradiol; Body mass index; Extraction immunoassay; Metabolic syndrome; IL-8; Integrin β3; NF-κB; Putative biomarkers; Quantitative proteomics; Tandem mass spectrometry etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Cancer Nanotechnology
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Cancer Nanotechnology
Editor(s):
Short Description: Nanotechnology is the science of manipulating matter at the molecular scale to create devices with novel chemical, physical and biological properties, which has the potential to radically change how we diagnose and treat cancer.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the usage of nanostructures and the induction of nanoscale processes for the prevention, diagnosis and treatment of cancer. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Cancer, Nanotechnology, Nanomedicine, Nanoparticle, Carbon Nanotubes, Imaging etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
Carcinogenesis & Mutagenesis
Guest Editor : Yushan Zhang,University of Florida ,USA.
Tentative Date: December, 2017
Submit Abstract
Join as an Editor
Carcinogenesis & Mutagenesis
Guest Editor : Yushan Zhang,University of Florida ,USA
Short Description: Carcinogenesis is literally the 'creation' of cancer. It is a process by which normal cells are transformed into cancer cells. Mutagenesis is a process by which the genetic information of an organism is changed in a stable manner, resulting in a mutation. It may occur spontaneously in nature, or as a result of exposure to mutagens.
Aims & Scope: In this special issue the editor asks the responsible authors to review the latest understanding of the evaluation and characterization of carcinogens and mutagens and also the application of current methods in molecular and cellular biology. This special issue would like to provide a platform wherein your contributions to the specified theme are accepted and discussions are made with regard to the scientific progress made in the respective theme. This special issue includes original article, short communication, mini-review and review articles.
Keywords: (Including and not limited to) Carcinogenesis, Mutagenesis, Change in genetic material of organism, How and why mutations occur, Cancer causes, Role of radiation etc.,
Schedule:
Confirmation deadline: November 30, 2017
Manuscript submission deadline: December 31, 2017
Revision Due: January 20, 2018
Release of special issue: February 10, 2018
Description
International Journal of Cancer Studies & Research (IJCR) is an international journal publishing articles that emphasize all major areas of Cancer Studies & Research and its diagnosis. IJCR has become an international, interdisciplinary forum for the publication of basic science and clinical research papers.
IJCR thrives on promoting intellectual, scholarly and coterminous research work in the field of Cancer Studies & Research. Therefore, IJCR has taken an initiative step by introducing “Special Issues”. All articles are rigorously reviewed. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes original research articles, review articles, clinical studies and mini-reviews on topics of wide interest to investigators in the field of Cancer Studies.
